Siren, L.L.C. Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0002005245
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2024 · 110 positions · Total reported value $1.99B · Top-10 concentration 41.6% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 55.7% · 15 new · 36 cut · 22 exited
Active Share (vs S&P 500): 97.6% · vs QQQ: 97.6% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -13.5% · vs SPY -15.6% · Prev Value $4.93B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -4.2% · vs SPY -6.4% · Latest Value $4.21B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2024 13F filing, Siren, L.L.C. disclosed 110 equity positions with a combined reported value of $1.99B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 41.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2024 were KYMR ($140.56M), ONC ($126.47M), SRRK ($90.19M). By sector, the heaviest allocations are Health Care 69.5%, Technology 4.7%.
Versus the prior quarter, Siren, L.L.C. opened 15 new positions, trimmed 36 and fully exited 22, a turnover rate of 55.7% of positions.
The largest new positions opened in Q3 2024 were KYMR ($140.56M), ONC ($126.47M), SRRK ($90.19M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2024)
- KYMR Kymera Therapeutics, Inc. · $140.56M
- ONC BEONE MEDICINES LTD · $126.47M
- SRRK Scholar Rock Holding Corporation · $90.19M
- BCAX Bicara Therapeutics Inc · $78.26M
- ARGX ARGENX SE · $77.87M
- CRNX CRINETICS PHARMACEUTICALS IN · $66.92M
- RNAM AVIDITY BIOSCIENCES INC · $66.17M
- APLS APELLIS PHARMACEUTICALS INC · $62.50M
Fully Exited (vs previous quarter)
No tracked position was fully exited this quarter.
Insider Transactions (Form 4)
Latest Siren, L.L.C. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Siren, L.L.C. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 116 positions worth $4.93B in total. HoldingsHub carries 8 quarters of its filings (Q3 2024–Q2 2026).
Portfolio Structure
- 116 positions · $4.93B reported value (Q2 2026)
- Top 10 holdings = 44.8% of reported value
- Largest position: SRRK (SCHOLAR ROCK HLDG CORP) at 10.7%
- Average position size: $42.48M
Sector Tilt
- Health Care 92.0%
- Information Technology 4.5%
- Consumer Discretionary 1.2%
- (classified holdings cover 99% of value)
Quarterly Activity
- Q2 2026: 25 new, 32 added, 21 reduced, 9 exited
- 38 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
2.97M | $140.56M | 7.08% | New | |
| 2 |
|
563.31K | $126.47M | 6.37% | New | |
| 3 |
|
11.26M | $90.19M | 4.54% | New | |
| 4 |
|
3.07M | $78.26M | 3.94% | New | |
| 5 |
|
143.65K | $77.87M | 3.92% | New | |
| 6 |
|
1.31M | $66.92M | 3.37% | New | |
| 7 |
|
1.44M | $66.17M | 3.33% | New | |
| 8 |
|
2.17M | $62.50M | 3.15% | New | |
| 9 |
|
38.92M | $61.10M | 3.08% | New | |
| 10 |
|
3.33M | $55.09M | 2.77% | New | |
| 11 |
|
3.26M | $52.11M | 2.62% | New | |
| 12 |
|
347.92K | $51.95M | 2.62% | New | |
| 13 |
|
2.83M | $51.48M | 2.59% | New | |
| 14 |
|
2.46M | $47.63M | 2.40% | New | |
| 15 |
|
5.72M | $46.91M | 2.36% | New | |
| 16 |
|
1.38M | $44.14M | 2.22% | New | |
| 17 |
|
1.13M | $40.76M | 2.05% | New | |
| 18 |
|
837.93K | $37.04M | 1.87% | New | |
| 19 |
|
2.61M | $34.43M | 1.73% | New | |
| 20 |
|
299.99K | $34.28M | 1.73% | New | |
| 21 |
|
753.60K | $34.18M | 1.72% | New | |
| 22 |
|
682.20K | $34.08M | 1.72% | New | |
| 23 |
|
9.97M | $33.50M | 1.69% | New | |
| 24 |
|
903.23K | $30.10M | 1.52% | New | |
| 25 |
|
743.77K | $29.28M | 1.48% | New | |
| 26 |
|
525.97K | $27.77M | 1.40% | New | |
| 27 |
|
1.34M | $26.18M | 1.32% | New | |
| 28 |
|
1.61M | $24.65M | 1.24% | New | |
| 29 |
|
834.03K | $24.30M | 1.22% | New | |
| 30 |
|
8.86M | $24.18M | 1.22% | New | |
| 31 |
|
1.21M | $20.28M | 1.02% | New | |
| 32 |
|
2.60M | $20.05M | 1.01% | New | |
| 33 |
|
2.75M | $19.16M | 0.96% | New | |
| 34 |
|
1.10M | $18.40M | 0.93% | New | |
| 35 |
|
920.56K | $15.28M | 0.77% | New | |
| 36 |
|
283.54K | $14.17M | 0.71% | New | |
| 37 |
|
418.83K | $14.00M | 0.70% | New | |
| 38 |
|
1.63M | $13.89M | 0.70% | New | |
| 39 |
|
192.43K | $12.95M | 0.65% | New | |
| 40 |
|
404.11K | $10.79M | 0.54% | New | |
| 41 |
|
1.11M | $10.39M | 0.52% | New | |
| 42 |
|
1.01M | $10.33M | 0.52% | New | |
| 43 |
|
250.00K | $10.02M | 0.50% | New | |
| 44 |
|
4.88M | $9.81M | 0.49% | New | |
| 45 |
|
22.00K | $9.46M | 0.48% | New | |
| 46 |
|
572.24K | $9.22M | 0.47% | New | |
| 47 |
|
1.73M | $8.53M | 0.43% | New | |
| 48 |
|
460.75K | $8.33M | 0.42% | New | |
| 49 |
|
4.00M | $7.88M | 0.40% | New | |
| 50 |
|
384.20K | $7.87M | 0.40% | New | |
FAQ
What did Siren, L.L.C. buy in 2024-Q3?
In its 2024-Q3 13F filing, Siren, L.L.C. reported 110 equity positions worth $1.99B in aggregate; its largest disclosed positions were KYMR ($140.56M), ONC ($126.47M), SRRK ($90.19M).
How large is Siren, L.L.C.'s portfolio?
Siren, L.L.C. reported $1.99B of long equity holdings across 110 positions as of 2024-Q3. Top-10 holdings account for 41.6% of reported value.
What is Siren, L.L.C.'s investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.